PI3Kα inhibition was found to enhance ER transcription by dephosphorylating and releasing KMT2D activity in breast cancer cells,18, 61 which leads to a rationale for targeting the epigenome and PI3K signalling. This evidence concerns the gene PIK3CA and breast cancer.